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Abstract
Background: There is no clear definition of osteogenesis imperfecta (OI). The most widely used
classification of OI divides the disease in four types, although it has been suggested that there may
be at least 12 forms of OI. These forms have been named with numbers, eponyms or descriptive
names. Some of these syndromes can actually be considered congenital forms of brittle bones
resembling OI (SROI).
Discussion: A review of different syndromes with congenital brittle bones published in the
literature is presented. Syndromes are classified in "OI" (those secondary to mutations in the type
I pro-collagen genes), and "syndromes resembling OI" (those secondary to mutations other that
the type I pro-collagen genes, identified or not). A definition for OI is proposed as a syndrome of
congenital brittle bones secondary to mutations in the genes codifying for pro-collagen genes
(COL1A1 and COL1A2).
Summary: A debate about the definition of OI and a possible clinical and prognostic classification
are warranted.
Background
Besides brittle bones, all other clinical characteristics of
osteogenesis imperfecta (OI) are variable, and even differ-
ent members of the same family may present with a dis-
similar degree of severity [1]. Severity appears to follow a
continuum in the OI population, and it is therefore very
difficult to establish a clinical prognostic classification in
definite categories. This disease has received different
names through history, including osteopsathyrosis, Vro-
lik's disease, fragilitas ossium, mollities ossium, Lob-
stein's disease, and Van der Hoeve syndrome [2]. In a first
attempt to classify OI, in 1906 Looser divided the disease
in two forms [3]: "congenita" (Vrolik) and "tarda" (Lob-
stein), depending on the severity of the presentation. In
OI congenita, multiple fractures may occur in-utero,
whereas in OI tarda, fractures happen at the time of birth
or later. OI tarda has also been sub-divided in "gravis" and
"levis" [3]. This classification is no longer tenable because
it failed to encompass the obvious clinical variability
apparent in this disorder. There has also been an attempt
to classify OI according to radiological characteristics [4].
Some of the features suggested by the authors of this clas-
sification are not present until age 5 or 10 years, and chil-
dren of early ages can not be classified using this scheme.
There has also been suggested that OI could be classified
OI according to severity [5,6]. The most commonly used
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divides the patients in four types (I-IV) [7,8]. In fact, it is
now widely recognized that there may be more types of OI
[9-11]. Some of the forms of congenital brittle bones have
been considered OI and have been added as numbers V,
VI and VII [8,12-14], while others have been designated
with eponyms (Cole-Carpenter syndrome [15], Bruck syn-
drome [16]), and others designated with clinical features
(OI with denser areas in bones [17], OI with optic atro-
phy, retinopathy, and severe psychomotor retardation
[18], OI with microcephaly, and cataracts [19], osteoporo-
sis-pseudoglioma syndrome). The numeric classification
(I-VII) is somewhat confusing, as the characteristics of
each type overlap. Furthermore, there is no consensus
about basic characteristics of the different types. For exam-
ple, it is not clear if type I OI includes individuals with
short stature, or if bone deformity rules out the diagnosis
of Type I OI. Also, it is unclear if an individual with nor-
mal height can have type IV OI. Type II OI is defined as
lethal, but there are cases of children with clinical charac-
teristics of type II OI who have survived several years. Fur-
thermore, the current classification does not allow for
prognostic predictions, as individuals with type I OI may
have numerous fractures and chronic pain in the course of
their lives. This is part of the lack of a precise definition of
OI. Thus, despite the fact that OI has been known for
more than 200 years, there is no consensus about the def-
inition for the disease. For some, it includes only those
forms of congenital brittle bones secondary to mutations
in the genes codifying for type I pro-collagen (COL1A1
and COL1A2). For others, it is a group of conditions with
the common feature of congenital brittle bones. The
example of the osteogenesis imperfecta-pseudoglioma
syndrome illustrates this concept very clearly. This syn-
drome has been re-named as "osteoporosis-pseudogli-
oma syndrome" once the causal mutation has been
identified to be in the LRP5 gene, elsewhere than the type
I pro-collagen genes [20,21]. Following this example, I
propose to define osteogenesis imperfecta as syndromes
resulting from mutations in either COL1A1 or COL1A2
genes, and to group all other syndromes with congenital
brittle bones as "syndromes resembling OI" (SROI),
pending the identification of their causal mutation. Here,
a review of the different forms of syndromes with congen-
ital brittle bones is presented (Table 1). A working-group
of international experts (like the Villefrance criteria in
Ehlers-Danlos Syndrome) to clarify the issue of definition
of congenital brittle bones syndromes and their classifica-
tion is warranted.
Discussion
Here, syndromes with congenital brittle bones are divided
in osteogenesis imperfecta (those secondary to mutations
in the type I pro-collagen genes) and syndromes resem-
bling OI (those secondary to mutations other than the
type I pro-collagen genes, identified or not)
Osteogenesis imperfecta (types are ordered 
based on severity from mild to severe)
Type I OI
The most common mutation causing OI type I causes a
reduction in the production of otherwise normal type I
collagen secondary to the effect of a null allele mutation.
Patients often have normal stature, and a slightly low stat-
ure does not preclude the diagnosis of type I OI. "Type I
OI" is not a synonymous of "mild OI". Individuals may
have few or no fractures, mostly during the first years of
life or even at birth [22], or numerous fractures through-
out their lives. They may have triangular face. They are
fully ambulatory, and do not have bowing of the long
bones, although vertebral fractures may be present. Most
have blue sclera, but it can be white, or blue color may
fade as the individual grows older. This condition is trans-
mitted as an autosomal dominant trait. Despite the
absence of fractures, bone density can be very low, with
no relation with clinical severity, underscoring the relative
lack of significance of bone density measurements assess-
ing severity in patients with OI. In many instances bone
density is normal during the first months of life, and indi-
viduals progressively fail to increase bone mineral density
with age. In some cases the diagnosis is an incidental find-
ing after a fracture [23]. Dentinogenesis imperfecta can be
present even in very mild cases. Early hypoacusia [24,25]
and cardio-vascular problems, particularly aortic valvular
disease [22] can be present in these subjects.
Type IV OI (Moderate OI with short stature)
These individuals typically have short stature, bowing of
long bones, and vertebral fractures. Scoliosis and joint lax-
ity may be present. Patients with this form of OI are gen-
erally able to ambulate, but they may require aids for
walking. Based in the presence of DI, moderate OI has
been sub-divided in two forms, "a" and "b" [26]. These
patients have white sclera. Precise diagnosis of this type of
OI is often difficult, as the clinical characteristics are not
clear in the literature, and different centers base the diag-
nosis on different criteria.
Type III OI (Severe OI)
These patients have triangular face, product of an enlarged
head and under-development of the facial bones. They
also have chest deformities, markedly short stature, and
severe deformities of the long bones, vertebral fractures,
and scoliosis. They are frequently wheelchair-bound,
although some are able to walk with aids. Prenatal diag-
nosis is hard but sometimes possible using ultrasonogra-
phy [27]. Long bones are severely bowed, and altered
structure of the growth plates lead to a particular structuralPage 2 of 6
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"popcorn appearance". Severe cases may have respiratory
complications that can compromise survival.
Type II OI
In this form of OI, most newborns do not survive the peri-
natal period. Causes of death are malformations or hem-
orrhages of the central nervous system [28], extreme
fragility of the ribs, or pulmonary hypoplasia [29]. The
infants present with multiple intra-uterine fractures,
including skull, long bones and vertebrae, beaded ribs,
and severe deformity of the long bones [30]. Prenatal dif-
ferential diagnosis between severe and lethal OI is usually
not possible. Extremely severe cases can be dismembered
during delivery [31]. The vast majority of cases are auto-
somal dominant new mutations [32-34]. It has been sug-
gested that there may be different clinical forms of lethal
OI [35]. Despite severity, a few patients have survived for
several years.
Congenital brittle bones with dense areas in bones
Described in one infant [17] who died shortly after birth
and presented with an OI phenotype that differed from
the usual lethal form. The skeleton had regions of
increased bone density, and this girl had dysmorphic
facial features, including loss of mandibular angle, low set
ears, soft skull, and large anterior and posterior fonta-
nelles. Bilateral upper and lower limb contractures were
present with multiple fractures in the long bones and ribs.
The metaphysis of the long bones were dense in x-rays.
The patient died after a few hours and histopathological
studies identified extramedullary hematopoiesis in the
liver, little lamellar bone formation, decreased number of
osteoclasts, abnormally thickened bony trabeculae with
retained cartilage in long bones, and diminished marrow
spaces similar to those seen in dense bone diseases such as
osteopetrosis and pycnodysostosis. Genetic testing
showed that the child was heterozygous for a
COL1A14321G → T transversion in exon 52 that changed
a conserved aspartic acid to tyrosine (D1441Y). Abnormal
proa1(I) chains were slow to assemble into dimers and
trimers, and abnormal molecules were retained intracellu-
larly for an extended period [17]. Because of this muta-
tion, this form of congenital brittle bones should be
included in the OI group.
Syndromes resembling OI (SROI)
Congenital brittle bones with craniosynostosis and ocular proptosis 
(Cole-Carpenter syndrome)
Two boys [15] and a girl [36] with this particular form of
SROI have been described in the literature. Both boys
were normal at birth, but after several months, they devel-
oped multiple metaphyseal fractures, associated with low
bone density in the entire skeleton and craniosynostosis,
hydrocephalus, ocular proptosis, and facial dysmor-
phism. One of the patients had also hypercalciuria. Neu-
rological development is normal in this form of SROI.
Both patients where wheelchair-bound at adult age, with
very short stature, severe bone involvement and normal
intellectual and neurological development [10]. No muta-
tion has been identified as causing this syndrome.
Congenital brittle bones with congenital joint contractures (Bruck 
syndrome)
First described by Bruck et al in 1897 in an adult patient
[16], in this form of SROI patients are born with brittle
bones, leading to multiple fractures and joint contractures
and pterygia (arthrogryposis multiplex congenita) due to
dislocation of the radial head [37,38]. Wormian bones are
present, and inheritance appears to be recessive [39,40].
Table 1: syndromes with congenital brittle bones
Osteogenesis Imperfecta
Mild OI with normal stature
Moderate OI with short stature
Severe OI
Lethal OI
Congenital brittle bones with dense areas in bones
Syndromes resembling OI (SROI)
Congenital brittle bones with craniosynostosis and ocular proptosis
Congenital brittle bones with congenital joint contractures
Osteoporosis-pseudoglioma syndrome
Congenital brittle bones with optic atrophy, retinopathy and severe psychomotor retardation
Congenital brittle bones with microcephaly and cataracts
Congenital brittle bones with redundant callus
Congenital brittle bones with mineralization defect
Congenital brittle bones with rhizomeliaPage 3 of 6
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testing, it was not possible to demonstrate any mutations
in the COL1A1 and COL1A2 genes [38]. The basic defect
was mapped to locus 17p12 (18 cM interval), where a
bone telopeptidyl hydroxylase is located [41]. The muta-
tion leads to underhydroxilated lysine residues within the
telopeptides of collagen type I, and therefore to aberrant
crosslinking in bone, but not in cartilage or ligaments.
Osteoporosis pseudoglioma syndrome [20,21]
This form of SROI was first described in three families in
1972 [42]. Other report described a South African family
of Indian origin with the condition [43]. Inheritance is
autosomal recessive. Individuals with Osteoporosis-pseu-
doglioma syndrome have mild to moderate OI with
blindness due to hyperplasia of the vitreous, corneal opac-
ity and secondary glaucoma. The ocular pathology may be
secondary to failed regression of the primary vitreal vascu-
lature during fetal growth [44]. The genetic defect has
been mapped to chromosome region 11q12-13 [45]. The
defect is specifically in the LRP5 gene that encodes for the
low-density lipoprotein receptor-related protein 5 [44].
Treatment with pamidronate has shown promising results
in this group of patients [46].
Other forms of SROI with ocular involvement
Two other forms of SROI with ocular involvement have
been described: one variant with optic atrophy, retinopa-
thy, and severe psychomotor retardation [18], another
with microcephaly and cataracts [19].
Congenital brittle bones with redundant callus formation
Originally published as "type V OI" [12]. Patients with
this syndrome develop hyperplastic calluses in long bones
after a fracture or intramedullary rodding surgery [22].
These patients present with hard, painful and warm swell-
ings over long bones which initially may suggest inflam-
mation or osteosarcoma. After a rapid growth period, the
size and shape of the callus may remain stable for many
years [47]. Microscopically there is increased production
of abnormal extracellular matrix, that is poorly organized
and incompletely mineralized in the callus area [48]. His-
tological studies in bone outside the callus area showed
that the bone lamellae are arranged in a mesh-like fash-
ion, as opposed to a parallel arrangement in patients with
OI [12]. A series of case reports of hyperplastic callus for-
mation in patients with clinical characteristics compatible
with OI can be found in the literature [3,47,49-54]. These
large calluses may also be present in flat bones [55].
These patients may also have calcification of the interos-
seous membrane between the radius and ulna, determin-
ing a clinical sign, as affected individuals are unable to
pronate and supinate the forearm. The radial head may be
dislocated. Patients with this syndrome have white sclera
and no DI. Mutations in the pro-collagen genes could not
be identified so far. Inheritance appears to be autosomal
dominant, with variable penetrance.
Congenital brittle bones with mineralization defect
Undistinguishable from moderate to severe OI on a clini-
cal basis, this rare form of SROI [13], has been classified
as "Type VI OI". It can only be diagnosed by bone biopsy,
where a mineralization defect affecting the bone matrix
and sparing growth cartilage is evident. These patients
have no DI and no wormian bones. Despite the histolog-
ical mineralization defect, there are no radiological signs
of growth plate involvement. The pattern of inheritance is
not clear, but the case of two siblings from healthy con-
sanguineous parents has been described, suggesting
gonadal mosaicism or a somatic recessive trait [13]. No
mutations of COL1A1 and COL1A2 genes have been
found in these patients, and collagen structure appears to
be normal. This form of SROI shares several characteristics
with fibrogenesis imperfecta ossium [56,57].
Congenital brittle bones with rhizomelia
A particular form of SROI with short humerus and reces-
sive inheritance was described in a First Nations commu-
nity of Quebec, and published as "type VII OI" [14]. The
individuals affected have short humeri and femora. The
phenotype is clinically moderate to severe. Fractures may
be present at birth, and the condition progresses to early
lower limb deformities, coxa vara and osteopenia. The
bone morphology in congenital brittle bones with rhi-
zomelia is not different than that of mild OI by histomor-
phometry. The genetic defect has been mapped to the
short arm of chromosome 3 by linkage studies [58], where
there are no genes that codify for type I pro collagen.
Summary
A definition for osteogenesis imperfecta is proposed based
on the presence of type I pro-collagen mutations. Inclu-
sion of related syndromes with unidentified mutations
should be considered as SROI until further defined. Dif-
ferent forms of syndromes with congenital brittle bones
are reviewed. A debate about the definition of OI and a
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